Supplementing SARS-CoV-2 genomic surveillance with PCR-based variant detection for real-time actionable information, the Netherlands, June to July 2021

Author:

Molenkamp Richard1,Fanoy Ewout2,Derickx Leonie3,de Groot Theun4,Jonges Marcel5,Leenstra Tjalling6,Nijhuis Roel7,Pas Suzan8,Vahidnia Ali9,von Wintersdorff Christian10,Mulder Bert4,Koopmans Marion1

Affiliation:

1. Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands

2. Public Health Service Rotterdam-Rijnmond, Rotterdam, the Netherlands

3. Public Health Service Gelderland-Zuid, Nijmegen, the Netherlands

4. Department of Clinical Microbiology and Infectious Diseases, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands

5. Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands

6. Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands

7. Laboratory for Medical Microbiology and Medical Immunology, Meander Medical Center, Amersfoort, the Netherlands

8. Microvida Laboratory for Medical Microbiology, Amphia Hospital, Breda, the Netherlands

9. Testing Agency, Ministry of Health, Welfare and Sport, Zeist, the Netherlands

10. Department of Medical Microbiology, Care and Public Health Research Institute (CAPHRI), Maastricht University Medical Centre (MUMC+), Maastricht, the Netherlands

Abstract

We evaluated routine testing with SARS-CoV-2 Delta variant-specific RT-PCR in regional hospital laboratories in addition to centralised national genomic surveillance in the Netherlands during June and July 2021. The increase of the Delta variant detected by RT-PCR correlated well with data from genomic surveillance and was available ca 2 weeks earlier. This rapid identification of the relative abundance and increase of SARS-CoV-2 variants of concern may have important benefits for implementation of local public health measures.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Subject

Virology,Public Health, Environmental and Occupational Health,Epidemiology

Reference10 articles.

1. A simple RT-PCR melting temperature assay to rapidly screen for widely circulating SARS-CoV-2 variants.;Banada;medRxiv,2021

2. Rapid screening method for the detection of SARS-CoV-2 variants of concern.;Ong;J Clin Virol,2021

3. SARS-CoV-2 variants, spike mutations and immune escape.;Harvey;Nat Rev Microbiol,2021

4. World Health Organization (WHO). Tracking SARS-CoV-2 variants. Geneva: WHO. [Accessed: 06 Oct 2021]. Available from: https://www.who.int/en/activities/tracking-SARS-CoV-2-variants

5. The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology.;Oude Munnink;Nat Med,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3